多年来,矽肺的临床治疗是对症治疗结合疗养,也探索了排矽和血液流变学的变化。1964年国内合成克矽平(oxypovidine,P_(204))以来,通过实验性矽肺预防性治疗,可阻止50-90％肺胶原的生成;病后治疗可逆转50-60％病情。70年代筛选出:铝制剂,哌喹类,汉防己甲素等药,临床治疗除改善患者症状外,尚有部分X线胸片出现了好转。现就几种常用矽肺治疗药物进行比较。 Over the years, the clinical treatment of silicosis is symptomatic treatment combined with convalescence, but also explores the silicon and blood rheology changes. Since the domestic synthesis of oxypovidine (P_ (204)) in 1964, the prevention of 50-90% pulmonary collagen production by experimental silicotic prophylaxis can be reversed; 50-60% of the cases can be reversed after treatment. Seventies selected: aluminum agents, piperacillin, tetrandrine and other drugs, in addition to improving the clinical treatment of patients with symptoms, there are still some X-ray showed improvement. Several commonly used silicosis treatment drugs are compared.